- Motif Bio (MTFB) (MTFB.L) [LON.MTFB], a clinical stage biopharmaceutical company specialising in developing novel antibiotics, will be giving a briefing to investors in London early next month.

It will take place on November 4 at an investor evening being organised by Shares Magazine. The event is supported by the London Stock Exchange and sponsored by AJ Bell Youinvest.

The presentation by Motif Bio, who are in discussions with pharmaceutical companies and universities to build a pipeline of innovative antibiotics, will be given by Richard C.E. Morgan, its Chairman.

The evening will take place at the Novotel Tower Bridge in Pepys Street, London EC3. The investor presentations start at 6.30 p.m.

Investors have the opportunity to register now for free:

At 11:11am: [LON:MTFB] Motif Bio Plc Ord 1p share price was 0p at 62p

Story provided by